REG - Induction Healthcare - Result of AGM

Induction HealthcareAnnouncement

06/09/2023 13:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230906:nRSF5963La&default-theme=true

RNS Number : 5963L  Induction Healthcare Group PLC   06 September 2023

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Results of 2023 Annual General Meeting ("AGM")

Induction Healthcare (AIM: INHC), a leading virtual care platform driving
digital transformation of healthcare systems worldwide, held its AGM today at
50 Liverpool Street, London EC2M 7PY at 9.00am (GMT).

 

The poll results on each resolution proposed are available on the Company
website.

 

All Ordinary Resolutions were passed.

 

 

Enquiries

 

 Induction

 Christopher Samler, Chair                              +44 (0)7712 194092

 Paul Tambeau, Chief Executive Officer                  +44 (0)7983 104443

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0)20 7496 3000
 Philip Davies

 

About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com/)

Induction (AIM: INHC) Induction delivers a suite of software solutions that
transforms care delivery and the patient journey through hospital. Our
system-wide applications help healthcare providers and administrators to
deliver care at any stage remotely as well as face-to-face - giving the
communities they serve greater flexibility, control and ease of access.
Purpose-built for integration with leading Electronic Medical Record (EMR)
platforms, our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGSSWFFMEDSEIU